Pre-Market Trading Commentary on High Volume Stocks: (NASDAQ: CYTK), (NASDAQ: ARRY)
Cytokinetics, Incorporated (NASDAQ: CYTK) and Families of Spinal Muscular Atrophy (FSMA) announced the award of a grant from FSMA to Cytokinetics to support preclinical research on muscle function in a mouse model of spinal muscular atrophy (SMA) to be conducted with the company`s fast skeletal muscle troponin activator, tirasemtiv. Financial details of the grant were not disclosed.
View full press release